EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A small regulatory RNA controls antibiotic adaptation in Staphylococcus aureus by modulating efflux pump expression

Kam Pou Ha iD, Etornam Kofi Kumeko iD, Philippe Bouloc iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01176-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Kam Pou Ha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CEA, CNRS, Institut de Biologie Intégrative de la Cellule (I2BC), Gif-sur-Yvette, Île-de-France, France. Hauptthemen laut MEDLINE: Staphylococcus aureus, Anti-Bacterial Agents, Bacterial Proteins, RNA, Bacterial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus is an opportunistic pathogen that poses a considerable burden to healthcare settings worldwide, aided by its ability to thrive in different environmental growth conditions and survive exposure to antibiotics. Small regulatory RNAs (sRNAs) are decisive in enhancing bacterial fitness by modulating gene expression in response to changing environmental conditions. We investigated the role of sRNAs in the adaptation of S. aureus to antibiotics. By assessing the fitness of a library of sRNA mutants, we identified that RsaA sRNA is required for optimal bacterial growth when exposed to low concentrations of fluoroquinolone, a class of antibiotics targeting DNA replication. We also found that in the absence of RsaA, S. aureus is less susceptible to β-lactam antibiotics, which act on the cell wall. RsaA has been reported to prevent the expression of MgrA, a master regulatory protein controlling the expression of efflux pumps. Here, we show that RsaA affects the sensitivity of S. aureus to fluoroquinolone and β-lactam antibiotics through MgrA. RsaA has two forms, a short one commonly referred to in RsaA studies, and a long form about twice the length, of which less is known. Interestingly, our phenotype was only restored when complemented with the long form of the gene or when it was supplied in two parts, the short form and the missing part to obtain the long form. This work demonstrates the role of regulatory RNAs in the adaptation of S. aureus to antibiotic resistance and highlights their value as potential therapeutic targets for manipulating individual sRNA responses to promote the efficacy of existing antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsRNA, BacterialRNA, Small UntranslatedGene Expression Regulation, BacterialMicrobial Sensitivity TestsFluoroquinolonesbeta-LactamsAdaptation, PhysiologicalMutation

Stichwörter der Autor:innen

MgrARsaAStaphylococcus aureusantibiotic susceptibilitycefazolinciprofloxacinfitnessnorfloxacinsmall regulatory RNAβ-bactam antibiotics

Substanzen

Anti-Bacterial AgentsBacterial ProteinsFluoroquinolonesRNA, Bacterialbeta-LactamsRNA, Small Untranslated

Autor:innen und Institutionen

  • Université Paris-Saclay, CEA, CNRS, Institut de Biologie Intégrative de la Cellule (I2BC), Gif-sur-Yvette, Île-de-France, France.

ORCID-Profile: Kam Pou Ha, Etornam Kofi Kumeko, Philippe Bouloc

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Ha, K. P., Kumeko, E. K., & Bouloc, P. (2025). A small regulatory RNA controls antibiotic adaptation in Staphylococcus aureus by modulating efflux pump expression. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01176-24

Vancouver

Ha KP, Kumeko EK, Bouloc P. A small regulatory RNA controls antibiotic adaptation in Staphylococcus aureus by modulating efflux pump expression. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01176-24

BibTeX
@article{Ha2025,
  author = {Ha, Kam Pou and Kumeko, Etornam Kofi and Bouloc, Philippe},
  title = {A small regulatory RNA controls antibiotic adaptation in Staphylococcus aureus by modulating efflux pump expression},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01176-24}
}
Kostenlos starten →